Merck KGaA (MKKGY)
OTCMKTS · Delayed Price · Currency is USD
25.02
-0.44 (-1.74%)
Sep 12, 2025, 3:58 PM EDT
Merck KGaA Market Cap
Merck KGaA has a market cap or net worth of $54.39 billion as of September 12, 2025. Its market cap has decreased by -35.46% in one year.
Market Cap
54.39B
Enterprise Value
63.65B
Revenue
24.92B
Ranking
n/a
PE Ratio
16.18
Stock Price
$25.02
Market Cap Chart
Since April 7, 1997, Merck KGaA's market cap has increased from 6.76B to 54.39B, an increase of 704.32%. That is a compound annual growth rate of 7.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 54.39B | -13.81% |
| Dec 30, 2024 | 63.11B | -8.87% |
| Dec 29, 2023 | 69.25B | -17.61% |
| Dec 30, 2022 | 84.06B | -24.78% |
| Dec 30, 2021 | 111.75B | 49.03% |
| Dec 30, 2020 | 74.98B | 45.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Elite Pharmaceuticals | 737.49M |
| Tian'an Technology Group | 732.84M |
| Glass House Brands | 577.09M |
| Northwest Biotherapeutics | 376.88M |
| CytoDyn | 367.97M |
| American Oncology Network | 353.19M |